Meridian

Meridian is a physician-supervised tirzepatide program formulated with a supportive cofactor (glycine or niacinamide), supporting appetite control through dual-receptor activation.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, engaging two complementary metabolic pathways. With supportive cofactors and ongoing clinician oversight, Meridian is designed for meaningful, sustained metabolic outcomes.